Title |
Structural genomics for membrane proteins
|
---|---|
Published in |
Cellular and Molecular Life Sciences, September 2006
|
DOI | 10.1007/s00018-006-6252-y |
Pubmed ID | |
Authors |
K. Lundstrom |
Abstract |
Structure-based drug discovery has proven useful in improving and shortening the drug development process. The approach of structural genomics to study a large number of targets in parallel has been commonly applied to protein families and even whole genomes. Paradoxically, although membrane proteins represent the largest type of drug targets, up to 70% today, determination of their structure has been modest compared to that of soluble proteins. Because membrane proteins are important for drug discovery an emphasis has been placed on developing technologies and methods to determine membrane protein structures. Several structural genomics initiatives have been established, focusing on the structural biology of membrane proteins. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 2 | 2% |
United Kingdom | 2 | 2% |
United States | 2 | 2% |
Australia | 1 | <1% |
Sweden | 1 | <1% |
France | 1 | <1% |
Canada | 1 | <1% |
Switzerland | 1 | <1% |
Greece | 1 | <1% |
Other | 1 | <1% |
Unknown | 108 | 89% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 35 | 29% |
Researcher | 31 | 26% |
Student > Master | 14 | 12% |
Professor | 9 | 7% |
Student > Bachelor | 8 | 7% |
Other | 17 | 14% |
Unknown | 7 | 6% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 51 | 42% |
Chemistry | 18 | 15% |
Biochemistry, Genetics and Molecular Biology | 14 | 12% |
Engineering | 8 | 7% |
Materials Science | 4 | 3% |
Other | 14 | 12% |
Unknown | 12 | 10% |